Epilepsiya i migren'


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Migraine and epilepsy are most common neurological diseases, manifested with paroxysmal disorders. The prevalence of epilepsy in people with migraine varies from 1 to 17% with a median of 5.9%, that is significantly higher than the average in the population (0.5%), and the prevalence of migraine in epileptic patients is 8-15%. Clinical manifestations of migrainous and epileptic attacks may be similar, making difficult differential diagnosis, for which the most important tool is history-taking. Electroencephalography (EEG) may be useful for patients with headache and signs of epilepsy, such as atypical aura or episodes of unconsciousness. Prolonged video-EEG monitoring is used as a differential diagnosis for migrainous and epileptic aura and objectification a comorbide migraine and epilepsy or migralepsy syndrome. In case of combination of migraine and epilepsy, drugs effective in both disorders (valproate and topiramate) should be preferred

全文:

受限制的访问

作者简介

A. Kotov

参考

  1. American Academy of Neurology Quality Standards Subcommittee. Practice parameter: the electroencephalogram in the evaluation of headache (summary statement). Report of the Quality Standards Subcommittee. Neurology. 1995;45:1411-13.
  2. Amery WK, Waelkens J, Caers I. Dopaminergic mechanisms in premonitory phenomena. In: Amery WK, Wauquier A, eds. The Prelude to the Migraine Attack. London: Bailliere Tindall; 1986:64-77.
  3. Amery WK, Waelkens J, Van den Bergh V. Migraine warnings. Headache. 1986;26:60-6.
  4. Andermann E, Andermann FA. Migraine-epilepsy relationships: epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:281-91.
  5. Andermann F. Clinical features of migraine-epilepsy syndrome. In: Andermann F1 Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:3-30.
  6. Andermann F. Migraine and epilepsy: an overview. In: Andermann F, Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:405-21.
  7. Appenzeller O. Posttraumatic headaches. In: Dalessio DJ, Silberstein SD, eds. Wolff's Headache and Other Head Pain. 6th ed. New York: Oxford University Press; 1993:365-83.
  8. BeaumanoirA, Jekiel M. Electrographic observations during attacks of classical migraine. In: Andermann F1 Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworths; 1987:163-80.
  9. Blau JN. Migraine prodromes separated from the aura: complete migraine. BMJ. 1980;281:658-60.
  10. Creange A, Zeller J, Rostaing-Rigattieri S, et al. Neurological complications of neurofibromatosis type 1 in adulthood. Brain. 1999;122:373-81.
  11. Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465-69.
  12. Ehrenberg BL. Unusual clinical manifestations of migraine, and "the borderland of epilepsy" re-explored. Semin Neurol. 1991;11:118-27.
  13. Fenwick P Episodic dyscontrol. In: Engel J, Pedley T, eds. Epilepsy: Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1998:2767-2774.
  14. Gastaut H. A new type of epilepsy: benign partial epilepsy childhood with occipital spike-waves. Clin Electroencephalogr. 1982; 13:13-22.
  15. Giffin NJ, Ruggiero L, Lipton RB, et al. A novel approach to the study of premonitory symptoms in migraine using an electronic diary. Neurology. 2003;60:935-40.
  16. Gronseth GS, Greenberg MK. The utility of the electroencephalogram in the evaluation of patients presenting with headache: a review of the literature. Neurology. 1995;45:1263-67.
  17. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura. Neurology. 1994;44:647-51.
  18. Lipton RB, Ottman R, Ehrenberg BL, et al. Comorbidity of migraine: the connection between migraine and epilepsy. Neurology. 1994; 44:28-32.
  19. Lipton RB, Silberstein SD. Why study the comorbidity of migraine? Neurology. 1994;44:4-5.
  20. Lipton RB, Silberstein SD, Stewart WF. An update on the epidemiology of migraine. Headache. 1994;34:319-28.
  21. Lipton RB, Stewart WF, Celentano DD, et al. Undiagnosed migraine headaches: a comparison of symptom-based and reported physician diagnosis. Arch intern Med. 1992; 156:12 73-78.
  22. Lipton RB, Stewart WF1 Diamond S, et al. Prevalence and burden of migraine in the United States: data from the American Migraine Study ii. Headache. 2001;41:646-57.
  23. Maria BL, Neufeld JA, Rosainz LC, et al. Central nervous system structure and function in Sturge-Weber syndrome: evidence of neurologic and radiologic progression. J Child Neurol. 1998;13:606-18.
  24. Marks DA, Ehrenberg BL. Migraine related seizures in adults with epilepsy, with EEG correlation. Neurology. 1993;43:2476-83.
  25. Mathew NT. Valproate in the treatment of persistent chronic daily headache. Headache. 1990;30:301.
  26. Multon S, Schoenen J. Pain control by vagus nerve stimulation: from animal to man..and back. Acta Neurol Belg. 2005;105:62-67.
  27. Ottman R, Lipton RB. Comorbidity of migraine and epilepsy. Neurology. 1994;44:2105-10.
  28. Panayiotopoulos CP. Difficulties in differentiating migraine and epilepsy based on clinical and EEG findings. in: Andermann F, Lugaresi E, eds. Migraine and Epilepsy. Boston: Butterworth; 1987:31-46.
  29. Panayiotopoulos CP. Benign childhood epilepsy with occipital paroxysms: a 15-year prospective study. Ann Neurol. 1989;26:51-6.
  30. Panayiotopoulos CP. Differentiating occipital epilepsies from migraine with aura, acephalgic migraine and basilar migraine. in: Panayiotopoulos CP1 ed. Benign Childhood Partial Seizures and Related Epileptic Syndromes. London: John Libbey & Company Ltd.; 1999:281-302.
  31. Pearce JMS. Migraine: a cerebral disorder. Lancet. 1984;11:86-9.
  32. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the international League Against Epilepsy. Epilepsia. 1989;30:389-99.
  33. Selby G, Lance JW. Observation on 500 cases of migraine and allied vascular headaches. J Neurol Neurosurg Psychiatry. 1960;23:23-32.
  34. Sianard-Gainko J, Lenaerts M, Bastings E, et al. Sodium valproate in severe migraine and tensiontype headache: clinical efficacy and correlations with blood levels. Cephalalgia. 1993;13:252.
  35. Silberstein SD, Lipton RB. Epidemiology of migraine. Neuroepidemiology. 1993;12:179-94.
  36. Silberstein SD, Lipton RB. Overview of diagnosis and treatment of migraine. Neurology. 1994; 44:6-16.
  37. Silberstein SD, Saper JR, Freitag F. Migraine: diagnosis and treatment. in: Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolff's Headache and Other Head Pain. 7th ed. New York: Oxford University Press; 2001:121-237.
  38. Silberstein SD, Young WB. Migraine aura and prodrome. Semin Neurol. 1995;45:175-82.
  39. So NK, Andermann F. Differential diagnosis. in: Engel J, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven Publishers; 1997:791.
  40. Sorensen KV. Valproate: a new drug in migraine prophylaxis. Acta Neurol Scand. 1988;78:346-48.
  41. Ziegler DK, Hassanein RS. Specific headache phenomena: their frequency and coincidence. Headache. 1990;30:152-56.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##